Leptomeningeal dissemination of cerebellar malignant astrocytomas

被引:25
作者
Endo, H
Kumabe, T
Jokura, H
Shirane, R
Ariga, H
Takai, Y
Yoshimoto, T
机构
[1] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Radiat Oncol, Sendai, Miyagi 9808574, Japan
关键词
cerebellum; leptomeningeal dissemination; malignant astrocytoma;
D O I
10.1023/A:1023983518341
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary malignant astrocytomas of the cerebellum are extremely rare, and the dissemination patterns and effectiveness of postoperative radiation therapy are unclear. Five consecutive cases of histologically proven cerebellar malignant astrocytoma, two anaplastic astrocytomas, one anaplastic pilocytic astrocytoma, and two glioblastomas, were treated between 1997 and 2001. Four patients underwent surgical removal, local irradiation, and chemotherapy, and one patient with anaplastic pilocytic astrocytoma received subtotal removal followed by gamma knife radiosurgery for the residual tumor. Two patients had no recurrence at the primary site. All patients developed leptomeningeal dissemination. Four patients had supratentorial dissemination and two patients had spinal metastases. The time interval between the diagnosis of the primary cerebellar tumor and the diagnosis of leptomeningeal dissemination was 5-29 months (mean 14.6+/-10.4 months). All patients died at 10-38 months (mean survival 22.2+/-13.6 months). Intensive treatment including chemotherapy and radiotherapy may be required in cerebellar malignant astrocytomas, considering the high incidence of symptomatic leptomeningeal dissemination.
引用
收藏
页码:191 / 199
页数:9
相关论文
共 34 条
[1]   LEPTOMENINGEAL DISSEMINATION OF MALIGNANT GLIOMAS - INCIDENCE, DIAGNOSIS AND OUTCOME [J].
ARITA, N ;
TANEDA, M ;
HAYAKAWA, T .
ACTA NEUROCHIRURGICA, 1994, 126 (2-4) :84-92
[2]   LEPTOMENINGEAL METASTASIS FROM SUPRATENTORIAL MALIGNANT GLIOMAS [J].
AWAD, I ;
BAY, JW ;
ROGERS, L .
NEUROSURGERY, 1986, 19 (02) :247-251
[3]  
Aziz T Z, 1990, West Engl Med J, V105, P39
[4]   Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse [J].
Brada, M ;
Hoang-Xuan, K ;
Rampling, R ;
Dietrich, PY ;
Dirix, LY ;
Macdonald, D ;
Heimans, JJ ;
Zonnenberg, BA ;
Bravo-Marques, JM ;
Henriksson, R ;
Stupp, R ;
Yue, N ;
Bruner, J ;
Dugan, M ;
Rao, S ;
Zaknoen, S .
ANNALS OF ONCOLOGY, 2001, 12 (02) :259-266
[5]  
CARMICHAEL F, 1928, J PATHOL, V31, P493
[6]  
CHAMBERLAIN MC, 1990, CANCER, V65, P337, DOI 10.1002/1097-0142(19900115)65:2<337::AID-CNCR2820650226>3.0.CO
[7]  
2-P
[8]   CEREBELLAR GLIOBLASTOMA IN CHILDHOOD [J].
CHIN, HW ;
MARUYAMA, Y ;
TIBBS, P ;
MARKESBERY, W ;
YOUNG, B .
JOURNAL OF NEURO-ONCOLOGY, 1984, 2 (01) :79-84
[9]   Malignant gliomas of the cerebellum: An analytic review [J].
Djalilian, HR ;
Hall, WA .
JOURNAL OF NEURO-ONCOLOGY, 1998, 36 (03) :247-257
[10]   GLIOBLASTOMA MULTIFORME IN CHILDREN [J].
DOHRMANN, GJ ;
FARWELL, JR ;
FLANNERY, JT .
JOURNAL OF NEUROSURGERY, 1976, 44 (04) :442-448